Dr. Annette Hay
Assistant Professor, Department of Medicine
Senior Investigator with the Canadian Cancer Trials Group (CCTG)
Dr. Hay is a hematologist and clinician scientist exploring CAR T-cell therapy, a revolutionary way of treating cancer.
In her talk, Dr. Hay has us imagine a world where cancer can be cured by a person’s own immune system. Instead of chemotherapy, radiation, or surgery, the work is done by a patient’s immune blood cells – removed, engineered to recognize cancer, and returned to the body.
Dr. Hay’s work with the Canadian Cancer Trials Group at Queen’s could help make that vision a reality. Her role as Senior Investigator includes testing new types of cell therapy products and new means of manufacturing them. Her areas of expertise also include hematological malignancies, data sharing, health economics, and adolescents and young adults with cancer.
Dr. Hay is committed to discovering new, groundbreaking approaches to treating cancer – and her Research Talk outlines the promise of cell therapy as a future game-changer.